Keyphrases
Immunoglobulin G
100%
Immunotoxin
100%
Pseudomonas Exotoxin A
100%
Site-specific Conjugation
100%
Anti-human Epidermal Growth Factor Receptor 2
100%
Trastuzumab
50%
Human Epidermal Growth Factor Receptor 2 (HER2)
50%
Unnatural Amino Acids
33%
Fragment Crystallizable
33%
Cytotoxicity
16%
Overexpressing
16%
Tumor Regression
16%
Fusion Protein
16%
Immunoglobulin
16%
Protein Synthesis
16%
Cellular Proteins
16%
Cysteine Residues
16%
Conjugation
16%
Conjugation Process
16%
Protein Conjugates
16%
Anticancer Therapeutics
16%
Immunogenicity
16%
Receptor-ligand Interaction
16%
Cancer Therapeutics
16%
Heavy Chain
16%
Antibody Fragment
16%
Azido Group
16%
Protein Molecules
16%
Elongation Factor 2
16%
Clinical Testing
16%
Preclinical Testing
16%
Bifunctional Linker
16%
Maleimide Group
16%
Antibody Protein
16%
Dibenzocyclooctadiene
16%
Antibody-mediated Immune Response
16%
Full-length Antibodies
16%
Toxic Fragments
16%
Unpaired Cysteine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin G
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Immunotoxin
100%
Pseudomonas Exotoxin
100%
Trastuzumab
50%
Amino Acid
33%
Malignant Neoplasm
33%
Cysteine
33%
Tumor Regression
16%
Receptor
16%
Infectious Agent
16%
Elongation Factor 2
16%
Cell Protein
16%
Immunoglobulin
16%
Immunogenicity
16%
Chimeric Protein
16%
Cytotoxicity
16%
Maleimide
16%
Immunology and Microbiology
Immunoglobulin G
100%
Pseudomonas
100%
Immunotoxin
100%
Gamma Urogastrone
100%
Exotoxin
100%
Trastuzumab
50%
Immunology
50%
Cell Line
16%
Immune Response
16%
Intravenous Immunoglobulin
16%
Infectious Agent
16%
Cytotoxicity
16%
Protein Synthesis
16%
Animal Experiment
16%
Conjugate
16%
Immunogenicity
16%
Heavy Chain
16%
Elongation Factor 2
16%
Fragment Crystallizable Receptor
16%